Skip to content

Adiponectin and Circulating Progenitor Cells (CPC) Function

Adiponectin Promotes the Migration of Circulating Progenitor Cells Through p38-mediated Induction of the CXCR4 Receptor

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01272674
Enrollment
20
Registered
2011-01-10
Start date
2011-01-31
Completion date
2011-03-31
Last updated
2015-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

Adiponectin and exercise training contribute to the maintenance of a normal vascular tone by influencing vascular NO bioavailability and concentration and function of endothelial progenitor cells. The molecular mechanisms are only partially understood. Therefore, aim of the present study is to elucidate the effects of Adiponectin on endothelial progenitor cell migration and the underlying signaling pathways. Furthermore, the impact of exercise training on adiponectin-mediated endothelial progenitor cell migration will be investigated.

Interventions

OTHERexercise training

4 weeks supervised physical exercise training

Sponsors

German Research Foundation
CollaboratorOTHER
Heart Center Leipzig - University Hospital
CollaboratorOTHER
University of Leipzig
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* ≤ 75 years of age * stable coronary artery disease * preserved left ventricular function * physical work capacity of ≥ 50 * successful elective percutaneous coronary intervention at study begin

Exclusion criteria

* diabetes mellitus * hypercholesterolemia * untreated hypertension * smoking * myocardial infarction within the last 4 weeks * significant stenosis of the left main coronary artery

Design outcomes

Primary

MeasureTime frame
migratory capacity of endothelial progenitor cells towards an SDF-1 gradient4 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026